70. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Skandinavischen Gesellschaft für Neurochirurgie
Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.
12.05. - 15.05.2019, Würzburg
Vorträge Montag, 13.05.2019
Tumour Treating Fields/Tumour treating fields
Meeting Abstract
(V001)
[Full Text]
The use of TTFields for newly diagnosed GBM patients in Germany in routine clinical care (TIGER – TTFields in Germany in routine clinical care)
Bähr O, Tabatabai G, Fietkau R, Goldbrunner R, Glas M[Full Text]
Meeting Abstract
(V002)
[Full Text]
Tumour-treating fields (TTF) with different settings in different glioma cell lines
Hatipoglu Majernik G, Berkelmann L, Bader A, Meshkar S, Krauss JK, Schwabe K, Manteuffel D, Ngezahayo A[Full Text]
Meeting Abstract
(V003)
[Full Text]
The blood brain barrier (BBB) permeability is altered by tumour treating fields (TTFields) in vitro and in vivo
Salvador E, Keßler AF, Schaeffer C, Burek M, Ruschig U, Brami CT, Sela TV, Giladi M, Ernestus RI, Löhr M, Förster C, Hagemann C[Full Text]
Meeting Abstract
(V004)
[Full Text]
The effect of tumour treating fields on cell morphology and invasion of different cancer cells
Kinzel A, Schneiderman R, Giladi M, Zeevi E, Shteingauz A, Voloshin T, Porat Y, Munster M, Kirson E, Palti Y[Full Text]
Meeting Abstract
(V005)
[Full Text]
Increased survival benefit for newly diagnosed glioblastoma patients with higher TTFields doses to the tumour bed
Kinzel A, Bomzon Z, Urman N, Lavy-Shahaf G[Full Text]
Meeting Abstract
(V006)
[Full Text]
Open-label phase 1 clinical trial testing personalised and targeted skull remodelling surgery to maximise TTFields intensity for recurrent glioblastoma – interim analysis and safety assessment (OptimalTTF-1)
Korshoej AR, Lukacova S, Sørensen JH, Hansen FL, Mikic N, Thielcher A, Cortnum SOS, Guldberg TL, Lassen-Ramshad Y, Rahbek C, Severinsen KE, von Oettingen GB[Full Text]
